Pelvic Organ Prolapse Clinical Trial
— CARESSOfficial title:
When to Remove the Indwelling Catheter After Minimally Invasive Sacrocolpopexy?
NCT number | NCT02189291 |
Other study ID # | 00010603 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2014 |
Est. completion date | December 31, 2018 |
Verified date | March 2019 |
Source | Oregon Health and Science University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Objectives
The objective of this study is to help identify the best practice regarding the use of
indwelling catheter after minimally invasive urogynecologic surgery. Investigators propose a
randomized controlled trial comparing the immediate removal of indwelling urethral catheter,
after minimally invasive sacrocolpopexy, to the present standard catheter removal on post
operative day one. Evidence based catheter management will be helpful to both providers and
patients in post-operative decision making.
Specific Aims
Aim 1: To demonstrate that immediate removal of catheter after minimally invasive
sacrocolpopexy results in shorter hospital stay than removal on postoperative day 1.
Aim 2: To demonstrate that immediate removal of catheter after minimally invasive
sacrocolpopexy confers no increased risk of re-catheterization.
Aim 3: To demonstrate that immediate removal of catheter after minimally invasive
sacrocolpopexy decreases the occurrence of urinary tract infection.
Design
A randomized controlled trial comparing the standard overnight indwelling urethral
catheterization with removal of catheter immediately post surgery after minimally invasive
sacrocolpopexy, at Oregon Health & Science University.
Outcome measures
Primary outcome measures are hospital stay in hours after completion of surgery and need for
re-catheterization. Hospital stay will be counted from the time the patient leaves the
operating room to the time she leaves the hospital. To avoid confounding, investigators are
only including the first / morning case of the day. For re-catheterization, investigators
will evaluate if patient was able to void after completion of surgery. Investigators will
compare the post voiding residuals, the need for re-catheterizations and the numbers of
patients going home with an indwelling catheter between the two groups. Investigators will
also compare the number of urinary tract infections, as documented by urine culture and
subsequent treatment, between the two groups.
Study Subjects
Study subjects will be women undergoing minimally invasive sacrocolpopexy. Women will be
invited to participate in the study during their preoperative visit. If they agree to
participation, this will be noted in their chart. Randomization to group will occur
immediately following surgery.
Status | Completed |
Enrollment | 72 |
Est. completion date | December 31, 2018 |
Est. primary completion date | July 1, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 21 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Women undergoing minimally invasive sacrocolpopexy - Sacrocolpopexy with or without concomitant procedures - Patients having the first start surgery of the day to standardize hospital time. Exclusion Criteria: - Elevated post void residual (PVR) - Mobility problems - Neurological conditions - Intra-operative cystotomy or urinary tract injury |
Country | Name | City | State |
---|---|---|---|
United States | St John Hospital & Medical Center | Detroit | Michigan |
United States | Legacy Good Samaritan Medical Center | Portland | Oregon |
United States | Oregon Health & Science University | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Hospital stay | Primary outcome measure is hospital stay in hours after completion of surgery. Hospital stay will be counted from the time the patient leaves the operating room to the time she leaves the hospital. | 4 weeks | |
Secondary | Re-catheterization | To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy confers no increased risk of re-catheterization. | Upto 4 weeks | |
Secondary | Urinary tract infection | To demonstrate that immediate removal of catheter after minimally invasive sacrocolpopexy decreases the occurrence of urinary tract infection. | upto 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05420831 -
Comparison of Vaginal and Laparoscopic Apical Fixation Techniques for Pelvic Organ Prolapse Treatment
|
N/A | |
Active, not recruiting |
NCT05422209 -
The Influence of Simultaneous Posterior Colporrhaphy and Perineoplasty on the Efficiency and Safety of Mesh-augmented Sacrospinal Fixation (Apical Sling) in Advanced POP Repair.
|
N/A | |
Completed |
NCT05493735 -
Lidocaine for Pessary Check Pain Reduction
|
Phase 3 | |
Completed |
NCT06126328 -
Materna Prep Study Phase II
|
Phase 2 | |
Recruiting |
NCT05542836 -
EVeRLAST 2-Year Follow-Up
|
||
Recruiting |
NCT05918367 -
Multicenter Ventral Mesh Rectopexy Registry Collaborative
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Recruiting |
NCT04807920 -
BOTOX® at the Time of Prolapse Surgery for OAB
|
Phase 4 | |
Completed |
NCT06268782 -
The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women
|
N/A | |
Recruiting |
NCT02919852 -
Laparoscopic Retrovesical Colpopectinopexia
|
N/A | |
Recruiting |
NCT03146195 -
The 3D Reconstruction Research of Pelvic Organ Prolapse Disease
|
N/A | |
Completed |
NCT02925585 -
Vaginal Tactile Imaging for Pelvic Floor Prolapse
|
||
Not yet recruiting |
NCT02536001 -
Prospective Randomized Study to Compare Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes
|
N/A | |
Recruiting |
NCT02113969 -
Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol
|
N/A | |
Completed |
NCT02383199 -
Polypropylene Mesh in Prolapse Surgery
|
N/A | |
Terminated |
NCT01673360 -
Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices
|
N/A | |
Completed |
NCT01842464 -
Sacro-Spinous Ligaments Anterior Apical Anchoring
|
N/A | |
Withdrawn |
NCT01530191 -
Factors Affecting Perioperative Outcomes
|
N/A | |
Completed |
NCT01320631 -
Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction
|
N/A | |
Completed |
NCT00581412 -
Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates
|
N/A |